Join AstraZeneca Vice President and Head of Data Office, Peder Blomgren, in this session to learn more about practical experiences from scaling transparent and ethical approaches to Data & AI, while delivering tangible business outcomes. AstraZeneca is an early adopter with broad internal capabilities and a rapidly increasing number of external AI partnerships, tackling a wide range of Data Science and AI innovation, from target and drug discovery, optimizing clinical trial study design, to digital health. The need therefore for transparent, ethical and well governed approaches to safeguard Data & AI value are paramount and seen as a business imperative. Peder will discuss some of these approaches, techniques and lessons learned.
Case study
Peder Blomgren
Vice President and Head of Data Office
Peder serves as a leading data pioneer in the global biopharma AstraZeneca - a company that has geared its strategy to rely on Data, AI and Digital as a foundational capability, to push the boundaries of science to deliver life-changing medicines.
He is the leader behind the Data Science & AI value program, the acclaimed Data & AI Ethics approach, and the rapid build of a Science-driven Data Office, geared to deliver world-class open analytics-ready science data with compliance by design. Leading data governance, his team rallies the organisation around data policy, FAIR data standards, and data strategy to achieve the highest priorities for pipeline impact.
Over his professional career, he has led businesses, departments, and drug projects - self-motivated with passion and drive, to achieve the unprecedented, and make a difference where it matters the most.
Read More
Read Less
He is the leader behind the Data Science & AI value program, the acclaimed Data & AI Ethics approach, and the rapid build of a Science-driven Data Office, geared to deliver world-class open analytics-ready science data with compliance by design. Leading data governance, his team rallies the organisation around data policy, FAIR data standards, and data strategy to achieve the highest priorities for pipeline impact.
Over his professional career, he has led businesses, departments, and drug projects - self-motivated with passion and drive, to achieve the unprecedented, and make a difference where it matters the most.
Wednesday, 11 May, 2022 / 02:15 PM - 02:45 PM BST